Revolution Medicines, Inc.
US ˙ NasdaqGS ˙ US76155X1000

SecurityRVMD / Revolution Medicines, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership28,473 shares
Latest Disclosed Value $ 1,047,521
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 90.17% decrease in ownership of RVMD / Revolution Medicines, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 28,473 shares of Revolution Medicines, Inc. (US:RVMD) valued at $1,047,522 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 289,741 shares of Revolution Medicines, Inc.. This represents a change in shares of -90.17% during the quarter. The current value of the position is $4,249,026 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Revolution Medicines EC US76155X1000 28,473 -261,268 -90.17 1,048 -89.78 0.0235
2025-05-28 2025-03-31 NP Revolution Medicines EC US76155X1000 289,741 7,527 2.67 10,245 -17.00 0.2458
2025-02-25 2024-12-31 NP REVOLUTION Medicines EC US76155X1000 282,214 -16,831 -5.63 12,344 -8.97 0.2695
2024-11-26 2024-09-30 NP REVOLUTION Medicines EC US76155X1000 299,045 34,909 13.22 13,562 32.29 0.2565
2024-08-26 2024-06-30 NP REVOLUTION Medicines EC US76155X1000 264,136 19,657 8.04 10,251 30.11 0.2088
2024-05-28 2024-03-31 NP REVOLUTION Medicines EC US76155X1000 244,479 -16,558 -6.34 7,880 5.25 0.1644
2024-02-26 2023-12-31 NP REVOLUTION Medicines EC US76155X1000 261,037 89,064 51.79 7,487 57.27 0.1598
2023-11-28 2023-09-30 NP REVOLUTION Medicines EC US76155X1000 171,973 -3,084 -1.76 4,760 1.67 0.1242
2023-08-25 2023-06-30 NP REVOLUTION Medicines EC US76155X1000 175,057 36,732 26.55 4,683 56.28 0.1111
2023-05-26 2023-03-31 NP REVOLUTION Medicines EC US76155X1000 138,325 21,109 18.01 2,996 7.31 0.0798
2023-02-24 2022-12-31 NP REVOLUTION Medicines EC US76155X1000 117,216 446 0.38 2,792 21.29 0.0768
2022-11-25 2022-09-30 NP REVOLUTION Medicines EC US76155X1000 116,770 18,879 19.29 2,303 20.71 0.0660
2022-08-25 2022-06-30 NP REVOLUTION Medicines EC US76155X1000 97,891 4,468 4.78 1,908 -19.97 0.0527
2022-05-26 2022-03-31 NP REVOLUTION Medicines EC US76155X1000 93,423 3,557 3.96 2,383 5.40 0.0555
2022-02-25 2021-12-31 NP REVOLUTION Medicines EC US76155X1000 89,866 0 0.00 2,262 -8.54 0.0491
2021-11-24 2021-09-30 NP REVOLUTION Medicines EC US76155X1000 89,866 0 0.00 2,472 -13.32 0.0545
2021-08-26 2021-06-30 NP REVOLUTION Medicines EC US76155X1000 89,866 25,151 38.86 2,852 -3.94 0.0612
2021-05-27 2021-03-31 NP REVOLUTION Medicines EC US76155X1000 64,715 4,559 7.58 2,969 24.70 0.0673
2021-02-25 2020-12-31 NP REVOLUTION Medicines EC US76155X1000 60,156 -2,595 -4.14 2,382 9.07 0.0610
2020-11-25 2020-09-30 NP REVOLUTION Medicines EC US76155X1000 62,751 38,004 153.57 2,184 179.51 0.0701
2020-08-27 2020-06-30 NP REVOLUTION Medicines EC US76155X1000 24,747 1,863 8.14 781 55.89 0.0255
2020-06-01 2020-03-31 NP REVOLUTION Medicines EC US76155X1000 22,884 22,884 501 0.0205
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.